DSM Integrated Annual Report 2020

Key business figures at a glance

Our activities are grouped in three clusters: Nutrition, Materials and Innovation Center. We report separately on Corporate Activities. Results presented in this section (and elsewhere in this Report) relate to consolidated activities only (therefore non-consolidated partnerships are excluded).

Net sales

x € million

 

2020

 

2019

 

 

 

 

 

Nutrition

 

6,365

 

6,028

Materials

 

1,518

 

1,744

Innovation Center

 

184

 

184

Corporate Activities

 

39

 

42

Total continuing operations

 

8,106

 

7,998

 

 

 

 

 

Discontinued operations

 

932

 

1,012

Total

 

9,038

 

9,010

Adjusted operating profit (EBIT)

x € million

 

2020

 

2019

 

 

 

 

 

Nutrition

 

919

 

881

Materials

 

168

 

270

Innovation Center

 

(17)

 

(12)

Corporate Activities

 

(141)

 

(150)

Total continuing operations

 

929

 

989

 

 

 

 

 

Discontinued operations

 

82

 

86

Total

 

1,011

 

1,075

Adjusted EBITDA

x € million

 

2020

 

2019

 

 

 

 

 

Nutrition

 

1,338

 

1,250

Materials

 

272

 

372

Innovation Center

 

21

 

26

Corporate Activities

 

(97)

 

(97)

Total continuing operations

 

1,534

 

1,551

 

 

 

 

 

Discontinued operations

 

116

 

133

Total

 

1,650

 

1,684

Capital employed at 31 December

x € million

 

2020

 

2019

 

 

 

 

 

Nutrition

 

8,308

 

6,731

Materials

 

953

 

1,060

Innovation Center

 

436

 

599

Corporate Activities

 

-

 

38

Total continuing operations

 

9,697

 

8,428

 

 

 

 

 

Discontinued operations

 

863

 

883

Total

 

10,560

 

9,311

Adjusted EBITDA margin

in %

 

2020

 

2019

 

 

 

 

 

Nutrition

 

21.0

 

20.7

Materials

 

17.9

 

21.3

Total continuing operations

 

18.9

 

19.4

 

 

 

 

 

Discontinued operations

 

12.4

 

13.1

Total

 

18.3

 

18.7

ROCE

in %

 

2020

 

2019

 

 

 

 

 

Nutrition

 

12.6

 

13.9

Materials

 

16.4

 

25.0

Total continuing operations

 

10.4

 

12.3

 

 

 

 

 

Discontinued operations

 

9.2

 

9.6

Total

 

10.3

 

12.0

Capital expenditure

x € million

 

2020

 

2019

 

 

 

 

 

Nutrition

 

441

 

420

Materials

 

63

 

84

Innovation Center

 

35

 

30

Corporate Activities

 

34

 

30

Total continuing operations

 

573

 

564

 

 

 

 

 

Discontinued operations

 

49

 

59

Total, accounting based

 

622

 

623

 

 

 

 

 

Non-cash items

 

(13)

 

4

Customer funding

 

(24)

 

(18)

Total, cash-based

 

585

 

609

 

 

 

 

 

In % of net sales

 

6.5

 

6.8

Workforce at 31 December

headcount

 

2020

 

2019

 

 

 

 

 

Nutrition

 

15,838

 

14,599

Materials

 

2,857

 

2,951

Innovation Center

 

579

 

683

Corporate Activities

 

2,039

 

2,087

Total continuing operations

 

21,313

 

20,320

 

 

 

 

 

Discontinued operations

 

1,814

 

1,854

Total

 

23,127

 

22,174

R&D expenditure (including associated IP expenditure)

 

 

x € million

 

as % of net sales

 

 

2020

 

2019

 

2020

 

2019

 

 

 

 

 

 

 

 

 

Nutrition

 

234

 

218

 

3.7

 

3.6

Materials

 

73

 

73

 

4.8

 

4.2

Innovation Center

 

60

 

57

 

32.6

 

31.0

Corporate Activities

 

11

 

13

 

28.2

 

31.0

Total continuing operations

 

378

 

361

 

4.7

 

4.5

 

 

 

 

 

 

 

 

 

Discontinued operations

 

60

 

55

 

6.4

 

5.4

Total

 

438

 

416

 

4.8

 

4.6